PRIMED-AI: Validation Center (U54 Clinical Trial Not Allowed) 
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The NIH Common Fund, in collaboration with other NIH Institutes and Centers, plans to issue a Notice of Funding Opportunity for the Precision Medicine with Artificial Intelligence - Integrating Imaging with Multimodal Data (PRIMED-AI) program. This initiative aims to develop advanced, cost-effective AI tools that combine clinical imaging with diverse health data to improve personalized care for patients with chronic and other health conditions. A key component of the program is the Validation Center, which will independently verify, validate, and assess the uncertainty of AI-enabled, image-based Clinical Decision Support tools by systematically retesting and harmonizing PRIMED-AI project outcomes to thoroughly evaluate their performance. Although applications are not currently being solicited, this advance notice is intended to give potential applicants adequate time to establish collaborations and prepare responsive proposals. The upcoming funding opportunity will use the U54 mechanism and excludes clinical trials. Researchers with expertise in validating clinical decision support technologies, particularly in understanding confidence intervals and failure modes of AI predictions, are encouraged to consider this future opportunity. The contract will be managed by the NIH Common Fund, with points of contact available for further inquiry.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The NIH Common Fund, with other NIH Institutes and Centers (ICs), intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Precision Medicine with Artificial Intelligence - Integrating Imaging with Multimodal Data (PRIMED-AI) program, which seeks to develop innovative, reliable, and cost-effective AI-based tools that integrate clinical imaging with other health data types to enhance personalized medicine for patients with chronic and other health conditions. The program’s Validation Center initiative will serve as an independent hub for third party verification, validation, and uncertainty quantification of AI-enabled, image-based, multimodal Clinical Decision Support (CDS) tools through the systematic retesting and harmonization of PRIMED-AI deliverables to comprehensively characterize performance of the CDS tools. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the U54 activity code. Investigators with expertise and insights into the validation of CDS tools and the confidence bounds and potential failure modes of AI predictions are encouraged to begin to consider applying for this new NOFO.
